BioFabUSA Logo

Advanced Regenerative Manufacturing Institute

Fast Facts

Established

December 2016

Website armiusa.org

Mission To develop a highly diverse, competitive, capable and innovative domestic cell, tissue and organ manufacturing ecosystem that will fundamentally change healthcare for chronic disease and traumatic injury; and to build the trained and ready workforce essential for that ecosystem.

Headquarters Manchester, NH

Consortium Organizer Advanced Regenerative Manufacturing Institute (ARMI)
Institute Metrics
 as of September 2024
 
168    Member Organizations

Total Ongoing and Completed Projects
76    Technology Projects
26    Education and Workforce Development (EWD) Projects

Education and Workforce Development
135,620    Participants in EWD Projects or Institute-led EWD Activities from FY20-FY24
Institute Snapshot
 
Significant breakthroughs in cell biology, biofabrication, and materials science in the last decade have laid the foundation for scalable manufacturing and commercialization of bioengineered and enabling technologies.  BioFabUSA targets the raw material, equipment, measurement, automation, logistics and analytics challenges that hinder scalable, consistent, and cost-effective manufacturing.  The development of bioengineered products on an industrial scale enables DoD to save lives on the battlefield, support force readiness, and restore form, function, and quality of life for service members, their families, and the broader public.
 


BioFabUSA's Tissue Foundry
Institute Capabilities
 
BioFab 
Foundry

BioFabUSA developed the first-ever scalable, modular, automated, and closed manufacturing platform for biofabrication.  The original Tissue Foundry (shown above) is composed of a series of subsystems, or modules, each representing a different stage of the manufacturing process for cell-based products. Modularity allows users to scale up and reconfigure the platform to facilitate the manufacture of a broad range of cell-based products; integration of programmable automation allows monitoring and data monitoring of process parameters, opening the door to process control; and automation allows for cost-effective operations at scale.  Finally, because the system is closed, the risk of contamination and process variability introduced by exposure to ambient air is mitigated.  This eliminates the need for costly capital investments in clean room facilities.  Modular, automated and closed manufacturing will ensure Warfighters and the Nation have access to high quality, consistent, and cost-effective cell-based products at industrial scale.
 
Deep
Tissue
Characterization
Center


The Deep Tissue Characterization Center is an integrated system of analytical instrumentation that supports the in-depth analysis of cell-based products and related components. Characterization, including cell count, multi-omics, and product-specific functional assays is essential for cost-effective development, regulatory advancement, clinical trial results, and production at scale.

 
Education &
Workforce
Development

BioFabUSA is building career pathways and training the skilled workforce for the biofabrication industry. By delivering industry-informed, accessible programming to thousands of students, educators, and industry stakeholders each year, BioFabUSA is closing educational skills gaps, speeding job placement, and strengthening the workforce for the defense industrial base. The Institute engages K-12 students in project-based learning, provides U.S. Department of Labor-approved Registered Apprenticeship Programs for biofabrication technicians and advanced manufacturing technicians, and convenes industry and academic partners to develop higher education curriculum that scales delivery and leads directly into biofabrication careers.